Clinical development
Trial design, development stages, and readouts.
Explore data
Snapshot · Sep 9, 2026The scale behind
the answer.
A view across the companies, drugs, targets, and clinical studies in Gosset. Explore the coverage, then follow the connections.
- 01Company records
- 193K
Organizations behind the programs
193,021 records - 02Drug records
- 152.7K
From preclinical research to approval
152,725 records - 03Targets & classes
- 8.8K
From our curated target ontology
8,795 records - 04Trial records
- 1M+
Including 221.5k interventional drug trials
Across the drug dataset
The development landscape.
One latest classification per drug record.
Latest reported stage
69,499 records with a stageLatest reported stages across current and historical drug records.
Clinical & approved drugs
Records classified as Phase 1–4 or approved- Phase 1–2
- 16,881
- Phase 3–4
- 6,148
- Approved
- 4,280
From coverage to context
Connect the full picture.
Follow an asset from its developer and target to its clinical progress, commercial activity, and supporting evidence.
Deals & company activity
Licensing, financing, and the organizations behind each program.
Targets & competition
Biology, modalities, and competing approaches.
Patents & evidence
Patent landscapes, publications, and source material.
Explore the underlying records and evidence with the full platform.
Explore the full platformA closer look
Try a public profile.
Explore selected company, drug and target profiles to see the data behind the numbers.
Selected companies with 10 or more drug assets.